Report of Foreign Issuer (6-k)
June 07 2017 - 3:37PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2017
Commission File Number: 001-32001
___________________
Aptose Biosciences Inc.
(Translation of registrant's name into
English)
5955 Airport Road, Suite 228
Mississauga, Ontario L4V 1R9
Canada
(
Address of principal executive offices
)
___________________
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
☒
Form
40-F
☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1)
☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7)
☐
DOCUMENTS FILED AS PART OF THIS FORM
6-K
See Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Aptose Biosciences Inc.
|
|
|
|
|
|
|
Date: June 7, 2017
|
|
|
|
By:
|
“
Gregory Chow
”
|
|
Name:
|
Gregory Chow
|
|
Title:
|
Senior Vice President and Chief Financial Officer
|
EXHIBIT LIST
99.1
|
|
Report of Voting Results
|
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aptose Biosciences (NASDAQ:APTO)
Historical Stock Chart
From Sep 2023 to Sep 2024